Jie Zhang

Shp2 in myocytes is essential for cardiovascular and neointima development.

Hongqiang Cheng, Xue Zhang, Y. Ke, 2019, Journal of molecular and cellular cardiology.

Daratumumab Prevents Experimental Xenogeneic Graft-Versus-Host Disease by Skewing Proportions of T Cell Functional Subsets and Inhibiting T Cell Activation and Migration

Yibo Wu, Xiaoqing Li, Haowen Xiao, 2021, Frontiers in Immunology.

Structural insights into Ras regulation by SIN1

David E. James, L. Ding, Guang Yang, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Endothelial deletion of SHP2 suppresses tumor angiogenesis and promotes vascular normalization

Hongqiang Cheng, Xue Zhang, Y. Ke, 2021, Nature Communications.

SHP2 deneddylation mediates tumor immunosuppression in colon cancer via the CD47/SIRPα axis

Hongqiang Cheng, Xue Zhang, K. Ying, 2023, The Journal of clinical investigation.

PDLIM5 inhibits STUB1-mediated degradation of SMAD3 and promotes the migration and invasion of lung cancer cells

Hongqiang Cheng, Xue Zhang, Y. Ke, 2020, The Journal of Biological Chemistry.

Endothelial Scaffolding Protein ENH (Enigma Homolog Protein) Promotes PHLPP2 (Pleckstrin Homology Domain and Leucine-Rich Repeat Protein Phosphatase 2)-Mediated Dephosphorylation of AKT1 and eNOS (Endothelial NO Synthase) Promoting Vascular Remodeling

Xinyan Wu, C. Xiao, Wen-Hsien Liu, 2020, Arteriosclerosis, thrombosis, and vascular biology.

SHP2 protects endothelial cell barrier through suppressing VE‐cadherin internalization regulated by MET‐ARF1

Luyang Yu, Hongqiang Cheng, Xue Zhang, 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.